ReviewFrontiers in physiology2021
An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk.
Sara Vázquez-Sánchez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled ittrialcites it